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Abstract
Aryl azides were treated with allenylmagnesium bromide to generate 1,5-disubstituted butynyl 1,2,3-triazoles in a
domino fashion, which upon Cu(I) catalyzed 1,3-dipolar cycloaddition with aryl azides afforded novel bis-1,2,3-
triazoles in quantitative yields. The final products were analyzed for their antimicrobial activities against a panel of
bacterial and fungal strains which revealed the products to be potent antimicrobials.
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1. Introduction
Most of the nitrogen-containing molecules are pharma-
cologically very active which can be attributed to the
fact that nitrogenous compounds are part and parcel of
the biomolecular diversity [1-7]. Amongst the pharma-
cologically active nitrogenous compounds, a large num-
ber of 1,2,3-triazoles and their derivatives attracted
considerable attention for the past few decades due to
their chemotherapeutical value. Many 1,2,3-triazoles,
including bis-triazoles, are found to be potent antimi-
crobial, analgesic, anti-inflammatory, local anesthetic,
anti-convulsant, anti-neoplastic, anti-malarial, and anti-
viral agents [8-10]. Some of them exhibited anti-prolif-
erative, anticancer activity, and several are used as DNA
cleaving agents and potassium channel activators. Such
type of diverse biological functions is also reported with
av a r i e t yo fbis-triazoles. The ‘click chemistry’ approach
has been the most widely used method for the synthesis
of libraries of a large number of biologically active mole-
cular frameworks particularly for the regioselective
synthesis of 1,2,3-triazoles, which involves the copper(I)-
catalyzed cycloaddition reaction between azides and
terminal alkynes (CuAAC). This reaction has been
termed as the ‘cream of the crop’ of ‘click reactions’ and
has found application in various facets of drug discovery
as it enables a modular approach to generate novel
pharmacophores utilizing a collection of reliable
chemical reactions [11,12]. Thus, the development of
the copper(I)-catalyzed ‘triazole click chemistry’ has led
to many interesting applications including the synthesis,
medicinal chemistry, molecular biology, and material
science. The bioorthogonality of azide and alkynes [13]
has allowed the use of their [3 + 2] cycloaddition in var-
ious biological applications including target guided
synthesis [14] and activity-based protein profiling [15].
Of particular interest would be the dimeric heterocycle-
based ligands which are designed for specific target
interactions. Various approaches reported for the synth-
esis of biologically relevant bis-triazoles include Cu(I)-
catalyzed 1,3-dipolar cycloaddition of monoazides with
diacetylenes or that of monoacetylenes with diazides.
For example, the synthesis of bis-triazoles is reported by
the reactions of bis(azidomethyl)benzenes with several
substituted acetylenes [16]. Recently, much attention has
been paid toward the synthesis and pharmacological
evaluation of triazoles and bis-triazoles as potent HIV-1
protease inhibitors [17,18] and size-specific ligands for
mRNA Hairpin loops [19], respectively. Keeping into
consideration the tremendous biological potence of tria-
zoles and bis-triazoles in general and the antimicrobial
activity in particular, we, in our continuous endeavor
toward the synthesis of pharmacologically active mole-
cules, designed the synthesis of novel unsymmetrical
bis-1,2,3-triazoles and then evaluated them for antimi-
crobial activities. The biological results obtained were
very interesting and revealed most of the synthesized
molecules to be potent antimicrobials. * Correspondence: abidrrl@gmail.com
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2.1. General methods
Melting points were recorded on Buchi Melting point
apparatus D-545; IR spectra (KBr disks) were recorded
on Bruker Vector 22 instrument. NMR spectra were
recorded on Bruker DPX200 instrument in CDCl3 with
TMS as internal standard for protons and solvent sig-
nals as internal standard for carbon spectra. Chemical
shift values are mentioned in δ (ppm) and coupling con-
stants are given in Hz. Mass spectra were recorded on
EIMS (Shimadzu) and ESI-esquire 3000 Bruker Dal-
tonics instrument. The progress of all reactions was
monitored by TLC on 2 × 5 cm pre-coated silica gel 60
F254 plates of thickness of 0.25 mm (Merck). The chro-
matograms were visualized under UV 254-366 nm and
iodine.
2.2.1. Chemical synthesis
2.2.1.1. General procedure for the synthesis of bis-
1,2,3-triazoles (5) To a suspension of Mg turnings (1.6
g, 0.66 mol, 10 equiv.) in specially dried THF with
HgCl2 (5 mg, 1% w/w of propargyl bromide) was added
propargyl bromide (3.05 ml of an 80% wt. soln. in
toluene, 4 mmol, 5 equiv.) in small portions while stir-
ring the mixture at r.t. (Note: A small grain of HgCl2 is
generally required to promote formation of the reagent.)
The mixture was stirred at r.t. for 2 h to give a cloudy
light green solution. The allenylmagnesium bromide
generated as above was cooled to 0°-5° and added drop-
wise to a solution of 3-methylphenyl azide (1 g, 0.007
mol) maintaining the temperature between 0 and 5°C.
The mixture was allowed to attain r.t., and stirring was
continued at ambient temperature for 30 min, followed
by quenching with aq. NH4Cl solution (10 mL) and
diluting with AcOEt (50 mL). The org. layer was sepa-
rated and the aq. layer extracted with AcOEt (2 × 20
mL). The combined org. layers were dried (anh.
Na2SO4) and evaporated under reduced pressure to
afford crude product, which was subjected to chromato-
graphy (silica gel, 60-120 mesh, elution; hexane/AcOEt
gradient) to afford pure 5-(But-3-yn-1-yl)-1-(3-methyl-
phenyl)-1H-1,2,3-triazoles 3 as a colorless liquid. 3-
Methyl butynyl triazole (10 mmol) was stirred in 5 mL
of tert-butanol and H2O (1:1 mixture). CuSO4 (12
mmol) and sodium ascorbate (50 mmol) were charged
into the reaction mixture. After 15 min, 3-methylphenyl
azide (10 mmol) was added to the above mixture, and
stirred for 8 h. The mixture was diluted with AcOEt,
the org. layer was separated, and the aq. layer extracted
with AcOEt (2 × 20 mL). The combined org. layers
were dried (anh. Na2SO4) and evaporated under reduced
pressure to afford crude product 5 (Scheme 1), which
was subjected to precipitation in hexane–AcOEt,
affording pure bis-triazole 5 as an amorphous brown
solid (only entries 2 and 13, see Table 1) (Scheme 2).
The analytical data of all the isolated bis-triazoles is
given as under.
1-(4-methoxyphenyl)-5-(2-(1-m-tolyl-1H-1,2,3-triazol-4-
yl)ethyl)-1H-1,2,3-triazole (5a)
Syrupy brownish liquid. IR (KBr) cm
-1: 3453, 2913, 2865,
1593, 1212, 1080, and 685;
1HN M R( C D C l 3): δ 2.44 (s,
3H); 3.12 (m, 4H); 3.87 (s, 3H); 7.02 (d, 2H, J =8 . 8 9
Hz); 7.35 (m, 6H); 7.50 (s, 1H), 7.60 (s, 1H);
13CN M R
(500 MHz, CDCl3): δ 21.40, 23.44, 24.53, 55.63, 114.74,
117.53, 119.41, 121.14, 126.71, 128.00, 129.53, 138.11,
140.03, 148.22, 161.12.; ESI-MS: 383 (M
+ +N a ) ;A n a l .
Calcd. for C20H20N6O: C, 66.65; H, 5.59; N, 23.32;
Found: C, 66.83; H, 5.38; N, 23.51.
4-(4-(2-(3-(4-methoxyphenyl)-3H-1,2,3-triazol-4-yl)
ethyl)-1H-1,2,3-triazol-1-yl)benz-oic acid (5b)
Amorphous white solid. m. p. 195-197°C; IR (KBr) cm
-1:
3413, 2922, 2860, 1593, 1234, 1017, and 690;
1HN M R
(CDCl3): δδ3.10 (t, 2H, J = 5.97); 3.12 (t, 2H, J = 5.97);
3.84 (s, 3H); 7.08 (d, 2H, J = 8.90 Hz); 7.37 (d, 2H, J =
8.90 Hz); 7.72 (s,1H), 7.93 (d, 2H, J = 8.63 Hz), 8.21 (d,
2H, J = 8.90 Hz); 8.33 (s, 1H);
13C NMR (500 MHz,
CDCl3): δ 22.50, 23.59, 54.45, 114.15, 115.43, 119.17,
119.21, 120.13, 126.36, 127.43, 130.78, 131.06, 147.23,
200.12; ESI-MS: 391 (M
+ + H); Anal. Calcd. for
C20H18N6O3:C ,6 1 . 5 3 ;H ,4 . 6 5 ;N ,2 1 . 5 3 ;F o u n d :C ,
61.71; H, 4.82; N, 21.79.
1-(4-methoxyphenyl)-5-(2-(1-(3-nitrophenyl)-1H-1,2,3-
triazol-4-yl)ethyl)-1H-1,2,3-triazole (5c)
Syrupy grayish semisolid. IR (KBr) cm
-1: 3393, 2897,
2867, 1582, 1244, 1018, and 689;
1H NMR (CDCl3): δ
3.10 (t, 2H, J = 5.78); 3.23 (t, 2H, J = 5.78); 3.85 (s, 3H);
7.05 (d, 2H, J = 8.94 Hz); 7.38 (d, 2H, J =8 . 9 4H z ) ;
7.73-7.88 (m, 2H); 8.22-8.32 (m, 2H); 8.42 (s, 1H); 8.68
(m, 1H);
13C NMR (500 MHz, CDCl3): δ 22.20, 23.69,
55.45, 113.15, 116.43, 118.17, 119.41, 120.13, 127.36,
127.43, 130.78, 132.06, 142.33, 148.25; ESI-MS: 392 (M
+
+ H); Anal. Calcd. for C19H17N7O3: C, 58.31; H, 4.38; N,
25.05; Found: C, 58.54; H, 4.5; N, 25.21.
1-(4-methoxyphenyl)-5-(2-(1-p-tolyl-1H-1,2,3-triazol-4-
yl)ethyl)-1H-1,2,3-triazole (5d)
Syrupy grayish semisolid. IR (KBr) cm
-1: 3423, 2932,
2876, 1593, 1234, 10179, and 694;
1HN M R( C D C l 3): δ
2.45 (s,3 H ) ;3 . 1 5( m ,4 H ) ;3 . 8 7( s ,3 H ) ;7 . 0 2( d ,2 H ,J =
8.89 Hz); 7.18 (d, 2H, J = 8.89 Hz), 7.37 (d, 2H, J =8 . 9 0
Hz); 7.47 (d, 2H, J = 8.90 Hz); 7.50 (s,1H), 7.80 (s, 1H);
13C NMR (500 MHz, CDCl3): δ 18.50, 22.23, 23.59,
54.45, 114.15, 115.43, 119.17, 119.51, 120.13, 126.36,
127.33, 130.78, 135.06, 147.23; ESI-MS: 383 (M
+ +N a ) ;
Anal. Calcd. for C20H20N6O: C, 66.65; H, 5.59; N, 23.32;
Found: C, 66.42; H, 5.68; N, 23.54.
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Entry Triazole Azide Bis-triazole
a Yield (%)
a 92
b 91
b
c 89
d 91
e 88
f 92
g 90
h 90
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zol-4-yl)ethyl)-1H-1,2,3-triazole (5e)
Syrupy grayish semisolid. IR (KBr) cm
-1: 3411, 2945,
2898, 1597, 1265, 1067, and 702;
1HN M R( C D C l 3): δ
3.17-3.40 (m, 4H); 7.34-7.57 (m, 2H); 7.77 (m, 2H), 7.86
(s, 1H); 8.17 (d, 2H, J = 7.85 Hz); 8.30 (d, 2H, J = 7.85),
8.55 (s, 1H);
13C NMR (500 MHz, CDCl3): δ 19.25,
21.23, 23.56, 114.15, 115.43, 119.17, 119.51, 120.13,
126.36, 128.33, 130.87, 136.06, 146.23; ESI-MS: 418 (M
+
+ Na); Anal. Calcd. for C18H14ClN7O: C, 54.62; H, 3.57;
N, 24.77; Found: C, 54.85; H, 3.38; N, 24.86.
1-(3-nitrophenyl)-5-(2-(1-m-tolyl-1H-1,2,3-triazol-4-yl)
ethyl)-1H-1,2,3-triazole (5f)
Syrupy brownish semisolid. IR (KBr) cm
-1: 3417, 2954,
2856, 1587, 1235, 1079, and 698;
1H NMR (CDCl3): δ
2.44 (s, 3H); 3.17-3.25 (m, 4H); 7.39 (d, 2H, J =7 . 4 0
Hz); 7.50 (s, 2H), 7.70-7.82 (m, 4H); 8.36 (m, 2H);
13C
NMR (500 MHz, CDCl3): δ 19.54, 21.23, 23.59, 114.15,
116.41, 119.17, 119.51, 120.13, 128.32, 127.35, 130.88,
136.06, 146.23, 153.22.; ESI-MS: 398 (M
+ +N a ) ;A n a l .
Calcd. for C19H17N7O2: C, 60.79; H, 4.56; N, 26.12;
Found: C, 60.95; H, 4.72; N, 26.34.
1-(3-nitrophenyl)-5-(2-(1-(3-nitrophenyl)-1H-1,2,3-tria-
zol-4-yl)ethyl)-1H-1,2,3-triazole (5g)
Scheme 1 Domino-click method for the synthesis of
unsymmetrical bis 1,2,3-Triazoles.
Scheme 2 Plausible mechanism for the formation of 5-butynyl
triazoles 3.
Table 1 Bis-triazoles prepared by ?‘?Domino-Click?’? reaction (Continued)
i 91
j 93
k 92
l 89
m 90
c
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-1: 3419, 2965,
2857, 1580, 1265, 1099, and 714;
1H NMR (CDCl3): δ
3.21 (t, 2H, J = 5.44); 3.30 (t, 2H, J = 5.44); 7.79 (m, 4H,
J = 7.40 Hz); 7.87 (s, 1H), 8.15 (d, 2H, J = 7.82 Hz); 8.38
( m ,2 H ) ,8 . 5 4( s ,1 H ) ;
13C NMR (500 MHz, CDCl3): δ
19.47, 21.34, 22.89, 114.15, 116.67, 119.77, 118.52,
120.13, 127.32, 128.35, 130.32, 136.18, 146.56, 154.31;
ESI-MS: 407 (M
+ + H); Anal. Calcd. for C18H14N8O4:C ,
53.20; H, 3.47; N, 27.57; Found: C, 53.11; H, 3.62; N,
27.34.
5-(2-(1-(3-nitrophenyl)-1H-1,2,3-triazol-4-yl)ethyl)-1-o-
tolyl-1H-1,2,3-triazole (5h)
Syrupy brownish semisolid. IR (KBr) cm
-1: 3418, 2954,
2856, 1587, 1235, 1079, and 698;
1H NMR (CDCl3): δ
2.36 (s, 3H); 3.09 (m, 4H); 7.22 (m, 2H); 7.43 (m, 4H),
7.68 (s, 1H); 7.71-7.84 (m, 2H), 8.17 (d, 1H, J = 7.66);
13C NMR (500 MHz, CDCl3): δ 18.54, 21.23, 23.59,
114.15, 117.41, 119.17, 119.51, 120.13, 128.32, 127.35,
130.88, 136.06, 146.23, and 155.23; ESI-MS: 398 (M
+ +
Na); Anal. Calcd. for C19H17N7O2:C ,6 0 . 7 9 ;H ,4 . 5 6 ;N ,
26.12; Found: C, 60.95; H, 4.72; N, 26.34.
1-o-tolyl-5-(2-(1-m-tolyl-1H-1,2,3-triazol-4-yl)ethyl)-1H-
1,2,3-triazole (5i)
Syrupy brownish semisolid. IR (KBr) cm
-1: 3417, 2944,
2856, 1587, 1235, 1079, and 695;
1H NMR (CDCl3): δ
2.07 (s, 3H); 2.15 (s, 3H); 3.12 (m, 2H); 7.54 (m, 2H);
7.63 (s, 1H); 7.74 (m, 3H), 8.08-8.23 (m, 3H); 8.57
(s,1H);
13C NMR (500 MHz, CDCl3): δ 19.68, 19.19,
21.58, 23.38, 116.10, 121.14, 122.22, 124.7, 129.82,
130.30, 131.31, 132.0, 135.80, 136.80, 137.83, 140.01,
148.20; ESI-MS: 367 (M
+ + Na); Anal. Calcd. for
C20H20N6: C, 69.75; H, 5.85; N, 24.40; Found: C, 69.90;
H, 5.52; N, 24.61.
5-(2-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)ethyl)-1-p-
tolyl-1H-1,2,3-triazole (5j)
Syrupy greyish semisolid. IR (KBr) cm
-1: 3427, 2966,
2865, 1576, 1235, 1079, and 687;
1HN M R( C D C l 3): δ
2.45 (s, 3H); 3.21-3.23 (m, 4H); 7.38-7.45 (d, 2H, J =
8.00 Hz); 7.70 (d, 2H, J = 8.00 Hz), 7.81 (m, 1H); 7.90
(m, 3H), 8.14 (m, 2H);
13C NMR (500 MHz, CDCl3): δ
19.85, 23.00, 23.54, 125.19, 125.27, 127.31, 129.71,
129.97, 130.89, 133.80, 134.97, 140.39, 144.60; ESI-MS:
367 (M
+ + Na); Anal. Calcd. for C19H17N7O2: C, 60.79;
H, 4.56; N, 26.12; Found: C, 60.61; H, 4.72; N, 26.29.
5-(2-(1-(3-nitrophenyl)-1H-1,2,3-triazol-4-yl)ethyl)-1-p-
tolyl-1H-1,2,3-triazole (5k)
Syrupy greyish semisolid. IR (KBr) cm
-1: 3417, 2986,
2865, 1576, 1233, 1089, and 677;
1HN M R( C D C l 3): δ
2.45 (s, 3H); 3.08-3.22 (m, 4H); 7.33 (s, 4H); 7.50 (s,
1H), 7.52-7.72 (m, 4H), 7.89 (d, 1H, J =7 . 8 9H z ) ;
13C
NMR (500 MHz, CDCl3): δ 15.82, 21.24, 23.33, 118.90,
122.73, 125.56, 130.23, 132.51, 133.69, 133.80, 135.61,
136.81, 139.97, 142.41, 144.43, 151.16; ESI-MS: 398 (M
+
+ Na); Anal. Calcd. for C19H17N7O2: C, 60.79; H, 4.56;
N, 26.12; Found: C, 60.92; H, 4.30; N, 26.26.
1-m-tolyl-5-(2-(1-m-tolyl-1H-1,2,3-triazol-4-yl)ethyl)-
1H-1,2,3-triazol (5l)
Amorphous brown solid; m.p. 175°C. IR (KBr) cm
-1:
3429, 3138, 2922, 2860, 1612, 1593, 1549, 1494, 1383,
1234, 1165, 1089, 1047, 1017, 980, 873, 849, 786, 690,
and 618;
1H NMR (CDCl3): 2.33 (s, 3H); 2.43 (s, 3H);
3.05 (t, 2H, J = 6.2 Hz); 3.20 (t, 2H, J = 6.2 Hz); 7.25-
7.59 (m, 8H); 7.73 (s, 1H); 8.36 (s, 1H).
13C NMR (500
MHz, CDCl3): 19.8, 19.9, 22.8, 23.8, 117.0, 120.4, 122.2,
125.7, 129.1, 129.8, 130.3, 132.0, 135.8, 136.8, 137.8,
140.0, 146.2. ESI-MS: 367 (M
+ +N a ) .A n a l .c a l c .f o r
C20H20N6 : C, 69.75; H, 5.85; N, 24.40; Found: C, 69.80;
H, 5.82; N 24.51.
2.2.2. Biology
The bacterial strains used for the analysis were Bacillus
subtilis (MTCC 619), Staphylococcus epidermidis
(MTCC 435), Proteus vulgaris (MTCC 426), and Pseudo-
monas aeruginosa (MTCC 424). The fungal strains used
were Aspergillus niger (MTCC 1344) and Penicillium
chrysogenum (MTCC 947). All the bacterial and fungal
strains were obtained from The Microbial Type Culture
Collection and Gene Bank (MTCC), Institute of Micro-
bial Technology (IMTECH), Chandigarh, India. Kena-
mycin and flucanazole were used as standard
antibacterial and antifungal substances, respectively,
under similar conditions for comparison. Dimethyl sulf-
oxide (DMSO) was used as negative control.
The test organisms were cultured on agar slants, incu-
bated 24 h at 37 ± 0.5°C and 24-48 h at 27 ± 0.2°C for
bacteria and fungi, respectively, to get the freshly pre-
pared cultures. The steroidal derivatives were evaluated
for antimicrobial activity against these freshly prepared
strains of test organisms by agar diffusion method
[20,21]. Muller Hinton Agar (MHA) and Potato Dex-
trose Agar (PDA) were used as nutrient media for bac-
terial and fungal strains, respectively. The media (MHA
&PDA) were prepared using distilled water and 20 mL
of it was transferred into 50-mL test tubes, the test
tubes were tightly plugged with cotton and sterilized in
autoclave at 15 lb/in
2 for 15 min as directed by the
manufacturer. After sterilization, the medium was
inoculated with freshly cultured bacterial strains under
sterile condition, i.e., under Laminar Flow. The inocula-
tion was done when the temperature of the medium
reached 50-40°C, so that test organism may not die at
higher temperature. The medium inoculated with test
microorganisms was transferred into the plates of 90-
mm size under sterile conditions. The medium was
allowed to solidify and the wells (4/plate) of 6-mm-dia-
meter and 50 μL volume were bored on it using sterile
cork borer. The solution of test compound 1000 μg/mL
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medium were each filled (50 μg) with test compound
using micropipette (20-200 μL). Four wells were bored
on the plates and each filled with same compound and
two plates for each test compound were taken and the
experiment was repeated twice. The disks of Kenamycin
and Flucanazole were also incorporated into the med-
ium for comparison (10-30 μg). The plates containing
test organism and test material in contact were incu-
bated at 37 ± 0.5°C for 24 h. Same procedure was
employed for antifungal activity; however, the culture
strains of fungi were maintained on PDA and spores
were transferred into the PDA medium and the plates
were incubated at 27 ± 0.2°C for 24-48 h. Inhibition of
growth of test organisms (bacterial & fungal) in pre-
sence of test material and standard was measured with
the help of standard scale and the mean values of inhi-
bition zones are reported in Table 2.
Table 2 gives the antimicrobial screening data
obtained after treating different microbial strains with
test doses of the different bis-triazolyl derivatives and
the values are reported in terms of zone of inhibition in
“mm”.
It is clear from the above data that all the compounds
3a-l showed significant antimicrobial activity against all
microbial strains used for testing. It is evident from the
data that even the position of substituent on the aro-
matic ring influences the relative activity which can be
attributed to their differences in either the bioavailability
or the protein-binding properties.
3. Results and discussions
The wide range of pharmacological activities especially
the antimicrobial potential [14,22-27] of triazole and
bis-triazole systems prompted us to design the synthesis
of a library of unsymmetrical bis-1,2,3-triazoles based on
a stepwise synthetic route involving domino addition of
allenylmagnesium bromide to aryl azides resulting in a
serendipitous formation of 5-butynylated triazoles in
good yields (> 70%) instead of 4-butynylated triazoles. 5-
Butynylated triazoles upon Cu(I) catalyzed 1,3-dipolar
cycloaddition with aryl azides generated bis-1,2,3-tria-
zoles in quantitative yields. The products together with
the approach for their synthesis being novel, the inter-
mediate 5-butynylated triazoles and the final product,
the bistriazole, were characterized by IR,
1H/
13CN M R ,
and mass spectral analysis. The intermediate 3 under-
goes a high yielding regioselective Cu(I) catalyzed 1,3-
dipolar cycloaddition with aryl azides (click reaction) to
afford quantitative yields of the product, i.e., bis-1,2,3-
triazoles, which were isolated in pure form after precipi-
tation. The isolated products were evaluated for their
antimicrobial activities against a panel of bacterial and
fungal cell lines. The biological results were highly
encouraging paving a way for the futuristic medicinal
chemistry work based on these scaffolds.
4. Conclusion
In conclusion, we have developed an unprecedented,
convenient strategy for the synthesis of novel, biologi-
cally important bis-1,2,3-triazoles employing a domino
Table 2 Antibacterial and antifungal screening data of compounds 5a-l
Compounds Zone of inhibition (mm)
Antibacterial activities Antifungal activities
B. subtilis (MTCC
619)
S. epidermidis (MTCC
435)
P. Vulgaris (MTCC
426)
P. aeruginosa (MTCC
424)
A. niger
(MTCC1344)
P. chrysogenum
(MTCC 947)
3a 08 09 10 12 - 10
3b 07 12 07 03 11 10
3c - 11 10 12 10 10
3d 11 12 - 12 12 12
3e 12 10 13 10 10 16
3f 09 14 14 - 13 14
3g 12 - 08 11 12 09
3h 14 12 10 10 11 10
3i 10 12 - 09 13 12
3j 08 - 10 11 11 12
3k 07 16 11 11 12 13
3l 10 09 11 08 09 13
Control - - - - - -
Kenamycin 23 24 22 17 - -
Flucanazole - - - 18 14
P. vulgaris, Proteus vulgaris; B. subtilis, Bacillus subtilis; S. epidermidis, Staphylococcus epidermidis; P. aeruginosa, Pseudomonas aeruginosa; DMSO, negative control;
well diameter/vol.- 6 mm/50 μl; Kenamycin, standard for antibacterial activity. Flucanazole, standard for anti fungal activity.
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Page 6 of 7reaction followed by the copper catalyzed ‘click’ proto-
col. The products thus obtained were found to be
potent antimicrobial agents.
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